Sotac Pharmaceuticals Stock Performance
|
|
|
Sotac Pharmaceuticals Company background
Founded in: 2015
Managing director: Sharadkumar Dashrathbhai Patel
Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of M/s Sotac Pharmaceuticals, pursuant to a Deed of Partnership dated October 28, 2015. Thereafter M/s. Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company in the name of Sotac Pharmaceuticals Private Limited dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on, Company converted into a Public Limited Company and the name of Company was changed to Sotac Pharmaceuticals Limited dated November 22, 2022 issued by Registrar of Companies, Ahmedabad.The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non BetaLactam (general) tablets, betalactam coated tablets, betalactam uncoated tablets, Non BetaLactam (general) capsules, betalactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream. The Companys therapeutic portfolio include AntiDiabetic, AntiPsychotic, Vitamins, Minerals, Iron, AntiCold, AntiAllergic, Derma Products, Antacid, AntiUlcerants, PPI, AntiEmetics, Cardiac, AntiHypertensives, Analgesic, AntiPyretic, AntiInflammatory, AntiBacterial, AntiViral, General Antibiotics IPLactams NonIPLactams, AntiFungal, Cephalosporin. Consequently, as a Group, it cater to a wide spectrum of companies for formulation development, clinical batch production, commercial scale productions.The Company commenced manufacturing facility in year 2017, which had an installed capacity to manufacture 90 Crore tables / year, 14 Crore Capsules / year. Later, in 2022, the Company acquired 71% holding in SOTAC Healthcare Private Limited and 100% holding in SOTAC Research Private Limited, thus making them as wholly owned Subsidiary Companies in April, 2022. Thereafter, it started a new venture, SOTAC Lifescience Private Limited and held 51% of total paidup capital in it. In April 2023, Company made an IPO of 3000000 fresh issue of Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 33 Crore.
Sotac Pharmaceuticals Financial Highlights
For the full year FY2025–2026, revenue
reached ₹100.88 crore and profit touched at
₹9.28 crore.
Sotac Pharmaceuticals Share Price Today
As of 18 Oct 2025, Sotac Pharmaceuticals share price is ₹125. The stock opened at ₹118.8 and had closed at ₹125 the previous day. During today’s trading session, Sotac Pharmaceuticals share price moved between ₹118.75 and ₹125.00, with an average price for the day of ₹121.88. Over the last 52 weeks, the stock has recorded a low of ₹88.05 and a high of ₹152.35. In terms of performance, Sotac Pharmaceuticals share price has increased by 5.3% over the past six months and has declined by 11.26% over the last year.
Sotac Pharmaceuticals Fundamental
Market Cap (in crs)
138.13
Face Value
10
Turnover (in lacs)
4.50
Key Metrics
Qtr Change %
41.96% Gain from 52W Low
-3.7
Dividend yield 1yr %
Low in industry
0.1
Sotac Pharmaceuticals Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Sotac Pharmaceuticals Quarterly Revenue
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
27.35 Cr | 25.25 Cr | 26.44 Cr | 25.74 Cr | 26.67 Cr |
Sotac Pharmaceuticals Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
100.88 Cr | 104.32 Cr | 77.83 Cr | 73.37 Cr | 48.95 Cr | 28.83 Cr |
Sotac Pharmaceuticals Quarterly Net Profit/Loss
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
0.42 Cr | 1.35 Cr | 1.74 Cr | 0.88 Cr | 0.21 Cr |
Sotac Pharmaceuticals Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
9.28 Cr | 3.58 Cr | 2.29 Cr | 2.88 Cr | -2.37 Cr | 0.09 Cr |
Sotac Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
125
Current Price
5Day EMA
123.30
10Day EMA
122.10
12Day EMA
122.10
20Day EMA
122.60
26Day EMA
123.10
50Day EMA
123.60
100Day EMA
123.80
200Day EMA
124.90
5Day SMA
123.80
10Day SMA
119.80
20Day SMA
123.30
30Day SMA
123.90
50Day SMA
125.50
100Day SMA
120.00
150Day SMA
123.80
200Day SMA
127.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 3600 Rs | 3600 Rs |
Week Rs | 3600 Rs | 3600 Rs |
Month Rs | null Rs | null Rs |
Resistance & Support
122.92
Pivot
Resistance
First Resistance
127.08
Second Resistance
129.17
Third Resistance
133.33
Support
First Support
120.83
Second support
116.67
Third Support
114.58
Relative Strength Index
52.18
Money Flow Index
48.95
MACD
-1
MACD Signal
-1.69
Average True Range
4.86
Average Directional Index
9.37
Rate of Change (21)
0.00
Rate of Change (125)
-13.19
Sotac Pharmaceuticals Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
80.31 | 127.86 | 78.06 | 140.95 | 81.08 | -3.36% | -10.46% | -23.45% | -39.40% | -16.04% | 1.50% | 16.34 | 40.71 | 1.29 | |
221.05 | 137.77 | 170 | 303 | 221.50 | 0.02% | -7.00% | -13.58% | -10.99% | 184.31% | 0.00% | 197.37 | 40.71 | 3.21 | |
138.60 | 142.07 | 129.1 | 224.5 | 139.50 | -0.43% | -3.52% | -7.60% | -24.10% | -2.19% | 2.16% | 11.73 | 40.71 | 1.04 | |
10.23 | 109.66 | 9 | 22.2 | 10.71 | -7.50% | -15.17% | -15.52% | -49.05% | 6.12% | 0.00% | 255.75 | 40.71 | 1.82 | |
5.93 | 139.69 | 2.82 | 6.57 | 6.05 | -1.98% | 12.31% | 85.31% | 27.80% | 589.53% | 0.00% | 296.50 | 40.71 | 4.46 | |
88.00 | 144.21 | 75.15 | 160 | 88.00 | 0.00% | -9.33% | -24.79% | -14.73% | 0.00% | 0.00% | 8.91 | 40.71 | 1.76 |
Sotac Pharmaceuticals Latest News
Sotac Pharmaceuticals Share Price FAQs
How has Sotac Pharmaceuticals shares performed in the past ?
Sotac Pharmaceuticals share price in the past 1-year return was -8.89. The Sotac Pharmaceuticals share hit a 1-year low of Rs. 88.05 and a 1-year high of Rs. 152.35.
What is the market cap of Sotac Pharmaceuticals ?
The market cap of Sotac Pharmaceuticals is Rs. 138.13 Cr. as of 14/10/2025.
What is the current P/E ratio of Sotac Pharmaceuticals ?
The PE ratios of Sotac Pharmaceuticals is 29 as of 14/10/2025.
What is the current PB ratio of Sotac Pharmaceuticals ?
The PB ratios of Sotac Pharmaceuticals is 2.6 as of 14/10/2025
How to buy Sotac Pharmaceuticals shares?
You can easily buy Sotac Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Sotac Pharmaceuticals ?
The 52-week high and low of Sotac Pharmaceuticals share price is ₹152.35 and ₹88.05 as of 14/10/2025.
Please be aware that Sotac Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Invest in Sotac Pharmaceuticals